Ovarian cancer in older women Journal Article


Authors: Tew, W. P.; Lichtman, S. M.
Article Title: Ovarian cancer in older women
Abstract: Advancing age is considered a risk factor for survival in ovarian cancer. Several groups reported at least a twofold increased risk of death in women older than 65 years of age. In this review, we will focus on several aspects of the management of ovarian cancer in the elderly, including the prognostic implications of advanced age, surgical considerations in the frail, chemotherapy options such as intraperitoneal (IP) treatment, and geriatric assessment in predicting toxicity. © 2008 Elsevier Inc. All rights reserved.
Keywords: cancer survival; aged; surgical technique; survival rate; cisplatin; doxorubicin; area under the curve; cancer growth; cancer risk; gemcitabine; paclitaxel; topotecan; outcome assessment; ovarian neoplasms; carboplatin; ovary cancer; blood toxicity; neuropathy; cyclophosphamide; docetaxel; aging; abdominal hysterectomy; geriatric assessment
Journal Title: Seminars in Oncology
Volume: 35
Issue: 6
ISSN: 0093-7754
Publisher: Elsevier Inc.  
Date Published: 2008-12-01
Start Page: 582
End Page: 589
Language: English
DOI: 10.1053/j.seminoncol.2008.08.007
PUBMED: 19027462
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 17 November 2011" - "CODEN: SOLGA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stuart Lichtman
    228 Lichtman
  2. William P Tew
    244 Tew